Abstract
Cholesteatoma is a destructive ear condition requiring complete surgical removal. One major problem lies in the frequent occurrence of residual cholesteatoma caused by squamous epithelium remaining in the middle ear. Our aim is to develop a laser treatment that is selectively directed against residual cholesteatoma cells and can be performed after cholesteatoma surgery in the same session. In a first trial, we studied the photodynamic effect of argon (AL) and diode lasers (DL) on cholesteatoma tissue. Intraoperatively harvested monolayer-cultured cholesteatoma cells were stained in vivo with different absorption enhancers: neutral red (NR), fluorescein diacetate (FDA), and indocyanine green (ICG). In vitro, staining tests on enhanced cellular dye absorption and laser tests were followed by cytotoxicity measurements to determine the respective amount of damage. To achieve selective cell destruction, antibody-mediated staining of cholesteatoma and middle ear mucosa cells was examined in a second trial. Cell cultures (cytospin and coverglass growing) and paraffin-embedded cholesteatoma tissue sections were studied immunohistochemically to determine the binding of monoclonal mouse antibodies against human cytokeratins CK5, CK10, CK14 and the epidermal growth factor receptor EGFR. Intracellular staining with absorption enhancers increased the optical density at the wavelength corresponding to the dye. Staining and subsequent laser irradiation destroyed up to 92% of cultured cholesteatoma cells. Unstained irradiated tissue was not affected. In cytospins, the antibody against CK5/6 showed strong staining of cholesteatoma and weak staining of mucosa cells. Reactivity for CK14 and EGFR was positive in both tissues. In coverglass cultures, staining of cholesteatoma cells was positive for CK5/6, CK14 and EGFR. Mucosa cells were positive for EGFR but negative for cytokeratins. Both cell types were negative for CK10. In embedded cholesteatoma tissue, CK5/6 and CK14 were localized in the basal layers of the matrix, while CK10 was situated in the suprabasal layers, and EGFR was present in all layers of the matrix and perimatrix. As for the technical aspects of laser-assisted cholesteatoma surgery, AL and DL have proved to be suitable devices; ICG and FDA are effective nontoxic absorption enhancers. The investigated antibodies against cytokeratins and EGFR show nonselective staining and thus appear to be inappropriate for avoiding unwanted cell damage. For safe and specific intraoperative application to intact tissue, the chromophore should be coupled to a particular antibody that binds solely to an easily accessible specific antigen at the surface of cholesteatoma cells.
Similar content being viewed by others
References
Abels C, Karrer S, Baumler W, Goetz AE, Landthaler M, Szeimies RM (1998) Indocyanine green and laser light for the treatment of AIDS-associated cutaneous Kaposi’s sarcoma. Br J Cancer 77:1021–1024
Arriaga MA, Dixon P (1998) Cytotoxicity of cytokeratin monoclonal antibody against keratinocytes: a possible therapeutic adjunct for cholesteatoma? Am J Otol 19:26–29
Baumler W, Abels C, Karrer S, Weiss T, Messmann H, Landthaler M, Szeimies RM (1999) Photo-oxidative killing of human colonic cancer cells using indocyanine green and infrared light. Br J Cancer 80:360–363
Broekaert D, Cornille A, Eto H, Leigh I, Ramaekers F, Van Muijen G, Coucke P, De Bersaques J, Kluyskens P, Gillis E (1988) A comparative immunohistochemical study of cytokeratin and vimentin expression in middle ear mucosa and cholesteatoma, and in epidermis. Virchows Arch A Pathol Anat Histopathol 413:39–51
Bujia J, Kim C, Holly A, Sudhoff H, Ostos P, Kastenbauer E (1996) Epidermal growth factor receptor (EGF-R) in human middle ear cholesteatoma: an analysis of protein production and gene expression. Am J Otol 17:203–206
De Corso E, Marchese MR, Scarano E, Paludetti G (2006) Aural acquired cholesteatoma in children: surgical findings, recurrence and functional results. Int J Pediatr Otorhinolaryngol 70:1269–1273
Dougherty TJ (2002) An update on photodynamic therapy applications. J Clin Laser Med Surg 20:3–7
Flock ST, Jacques SL (1993) Thermal-damage of blood-vessels in a rat skin-flap window chamber using indocyanine green and a pulsed Alexandrite laser—a feasibility study. Lasers Med Sci 8:185–196
Frenz M (2007) Physical characteristics of various lasers used in stapes surgery. Adv Otorhinolaryngol 65:237–249
Hamilton JW (2005) Efficacy of the KTP laser in the treatment of middle ear cholesteatoma. Otol Neurotol 26:135–139
Hsu YC, Ho KY, Chai CY, Lee KW, Wang LF, Wu SC, Kuo WR, Tsai SM (2003) Expression of epidermal growth factor receptor in human middle ear cholesteatoma. Kaohsiung J Med Sci 19:497–502
Ilgner J, Wehner M, Lorenzen J, Bovi M, Westhofen M (2006) Morphological effects of nanosecond- and femtosecond-pulsed laser ablation on human middle ear ossicles. J Biomed Opt 11:014004
Jackel MC, Martin A, Steiner W (2007) Twenty-five years experience with laser surgery for head and neck tumors: report of an international symposium, Gottingen, Germany, 2005. Eur Arch Otorhinolaryngol 264:577–585
Janda P, Sroka R, Baumgartner R, Grevers G, Leunig A (2001) Laser treatment of hyperplastic inferior nasal turbinates: a review. Lasers Surg Med 28:404–413
Jovanovic S (2007) Technical and clinical aspects of ‘one-shot’ CO(2) laser stapedotomy. Adv Otorhinolaryngol 65:255–266
Jovanovic S, Schonfeld U, Scherer H (2004) CO2 laser stapedotomy with the “one-shot” technique—clinical results. Otolaryngol Head Neck Surg 131:750–757
Kaylie DM, Gardner EK, Jackson CG (2006) Revision chronic ear surgery. Otolaryngol Head Neck Surg 134:443–450
Korting HC, Schindler S, Hartinger A, Kerscher M, Angerpointner T, Maibach HI (1994) MTT-assay and neutral red release (NRR)-assay: relative role in the prediction of the irritancy potential of surfactants. Life Sci 55:533–540
Lepercque S, Broekaert D, Van Cauwenberge P (1993) Cytokeratin expression patterns in the human tympanic membrane and external ear canal. Eur Arch Otorhinolaryngol 250:78–81
Liang J, Michaels L, Wright A (2003) Immunohistochemical characterization of the epidermoid formation in the middle ear. Laryngoscope 113:1007–1014
Lippert BM, Gottschlich S, Kulkens C, Folz BJ, Rudert H, Werner JA (2001) Experimental and clinical results of Er:YAG laser stapedotomy. Lasers Surg Med 28:11–17
Lund-Johansen P (1990) The dye dilution method for measurement of cardiac output. Eur Heart J 11(Suppl I):6–12
Misiolek M, Ziora D, Namyslowski G, Misiolek H, Kucia J, Scierski W, Kozielski J, Warmuzinski K (2007) Long-term results in patients after combined laser total arytenoidectomy with posterior cordectomy for bilateral vocal cord paralysis. Eur Arch Otorhinolaryngol 264:895–900
Olszewska E, Sudhoff H (2007) Comparative cytokeratin distribution patterns in cholesteatoma epithelium. Histol Histopathol 22:37–42
Palumbo G (2007) Photodynamic therapy and cancer: a brief sightseeing tour. Expert Opin Drug Deliv 4:131–148
Raslan W, Wiet RJ, Rybak LP (1989) Lessening cholesteatoma residual with laser: an experimental study. In: Tos M, Thomsen J, Peitersen E (eds) Proceedings of the third international conference on cholesteatoma and mastoid surgery, Copenhagen, 1988. Kugler, Amsterdam, pp 761–767
Reuter CW, Morgan MA, Eckardt A (2007) Targeting EGF-receptor-signalling in squamous cell carcinomas of the head and neck. Br J Cancer 96:408–416
Schindler S, Lanser MJ (1989) The surgical management of cholesteatoma. In: Tos M, Thomsen J, Peitersen E (eds) Proceedings of the third international conference on cholesteatoma and mastoid surgery, Copenhagen, 1988. Kugler, Amsterdam, pp 769–778
Sheehy JL, Brackmann DE, Graham MD (1977) Cholesteatoma surgery: residual and recurrent disease. A review of 1,024 cases. Ann Otol Rhinol Laryngol 86:451–462
Strunk CL Jr, Quinn FB Jr (1993) Stapedectomy surgery in residency: KTP-532 laser versus argon laser. Am J Otol 14:113–117
Sudhoff H, Borkowski G, Bujia J, Hildmann H, Fisseler-Eckhoff A (1997) Immunohistochemical studies with middle ear mucosal remnants in cholesteatoma. HNO 45:630–635
Teatini GP, Perria C, Iori G, Meloni F, Tanda F (1989) Hematoporphyrin uptake by experimentally induced cholesteatomas in an animal model. Arch Otorhinolaryngol 246:53–55
VanderWerf QM, Castro DJ, Nguyen RD, Paiva MB, Chao KH, Santillanes ME, Saxton RE (1997) KTP laser and neutral red phototherapy of human squamous cell carcinoma. Laryngoscope 107:316–320
Author information
Authors and Affiliations
Corresponding author
Additional information
The authors confirm the absence of financial involvement in any organization with a direct commercial interest and the absence of any off-label or investigational use.
Rights and permissions
About this article
Cite this article
Caffier, P.P., Marzahn, U., Franke, A. et al. Laser-assisted cholesteatoma surgery: technical aspects, in vitro implementation and challenge of selective cell destruction. Eur Arch Otorhinolaryngol 265, 1179–1188 (2008). https://doi.org/10.1007/s00405-008-0602-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00405-008-0602-3